Literature DB >> 8638830

Cardiovascular events in the postanesthesia care unit: contribution of risk factors.

D K Rose1, M M Cohen, D P DeBoer.   

Abstract

BACKGROUND: The purpose of this study was to determine the relationship of four postanesthesia care unit (PACU) cardiovascular events to long-term outcomes (unplanned critical care admission or mortality) and to evaluate the contribution of anesthetic management compared with other perioperative factors in predicting these events.
METHODS: For patients admitted to the PACU after receiving general anesthesia (n = 18,380), the risk of long-term outcomes was examined for patients in the PACU with hypertension, tachycardia, bradycardia, or hypotension. Using logistic regression (P < 0.05), risk factors (grouped as patients, surgical, anesthetic, operating room observations, and other PACU observations) for each cardiovascular event were determined. For each factor grouping, the relative contributions to each cardiovascular event were compared using maximum likelihood chi-square analysis.
RESULTS: Patients in the PACU with hypertension or tachycardia had more unplanned critical care admissions (2.6% and 4.0% vs. 0.2% for patients with no events) and greater mortality (1.9% and 2.3% vs. 0.3% and 0.4%) (P < 0.01). For PACU hypertension (rate 2.0%), age, smoking, renal disease, female gender, and angina were significant risk factors. For PACU tachycardia (0.9%), intraoperative tachycardia and dysrhythmia were the major contributors. Patient factors also increased the risk of bradycardia (2.5%); namely age, ASA physical status 1 or 2, and preoperative beta blocker therapy. For hypotension (2.2%), duration of surgery > 2 h, completion after 6 PM, and gynecologic intraabdominal procedures were significant risk factors. Compared to patient, surgical, intraoperative, or PACU observations, anesthetic factors studied (premedication, induction agent, ventilation, use of opioids) provided only a small contribution in predicting these events.
CONCLUSIONS: Hypertension and tachycardia in the PACU, although infrequent, are associated with increased risk of unplanned critical care admission and mortality. Patient, surgical, intraoperative, or PACU observations contribute more to cardiovascular events in the PACU than do differences in anesthetic management identified in this study.

Entities:  

Mesh:

Year:  1996        PMID: 8638830     DOI: 10.1097/00000542-199604000-00003

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  5 in total

1.  Postoperative emergency response team activation at a large tertiary medical center.

Authors:  Toby N Weingarten; Sam J Venus; Francis X Whalen; Brittany J Lyne; Holly A Tempel; Sarah A Wilczewski; Bradly J Narr; David P Martin; Darrell R Schroeder; Juraj Sprung
Journal:  Mayo Clin Proc       Date:  2012-01       Impact factor: 7.616

2.  Retrospective review of critical incidents in the post-anaesthesia care unit at a major tertiary hospital.

Authors:  Suze Dominique Bruins; Pauline Meng Choo Leong; Shin Yi Ng
Journal:  Singapore Med J       Date:  2016-07-21       Impact factor: 1.858

3.  Intra-operative tachycardia and peri-operative outcome.

Authors:  Bernd Hartmann; Axel Junger; Rainer Röhrig; Joachim Klasen; Andreas Jost; Matthias Benson; Helge Braun; Carsten Fuchs; Gunter Hempelmann
Journal:  Langenbecks Arch Surg       Date:  2003-08-14       Impact factor: 3.445

4.  Incidence and predictive factors associated with hemodynamic instability among adult surgical patients in the post-anesthesia care unit, 2021: A prospective follow up study.

Authors:  Melkam Mulugeta Abebe; Nurhusen Riskey Arefayne; Mamaru Mollalign Temesgen; Biruk Adie Admass
Journal:  Ann Med Surg (Lond)       Date:  2022-01-29

5.  Survey and management of anaesthesia related complications in PACU.

Authors:  Jafar H Faraj; A R R Vegesna; I N Mudali; M A Khairay; Shaikh Nissar; Muna Alfarhan; Kareema Sabir; Fawkia El-Imam; Lucy Anto; Teofila Go
Journal:  Qatar Med J       Date:  2013-11-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.